Navigation Links
YM BIOSCIENCES REPORTS ADDITIONAL RESULTS FROM NIMOTUZUMAB PHASE III STUDY IN CHILDREN WITH GLIOMA PRESENTED BY ONCOSCIENCE AG
Date:10/29/2009

MISSISSAUGA, ON, Oct. 29 /PRNewswire-FirstCall/ - YM BioSciences Inc. (NYSE Amex: YMI; TSX: YM), a life sciences product development company that identifies and advances a diverse portfolio of promising cancer-related products at various stages of development, today reported additional results from a completed phase III study of nimotuzumab in children with diffuse intrinsic pontine glioma (DIPG). The updates to the preliminary data at ASCO 2008 were presented by Oncoscience AG, YM's licensee for nimotuzumab in Europe, at the 41st Annual Meeting of the International Society of Pediatric Oncology (SIOP) held in Sao Paulo, Brazil from October 5th-9th, 2009.

"These results demonstrate that nimotuzumab continues its long record of differentiated and remarkable safety and that it brings important benefits to children with this disease who are otherwise subject to aggressive chemotherapy," said Ferdinand Bach, CEO of Oncoscience, the sponsor of the trial. "These additional results showed that the benefit of nimotuzumab, in combination with radiotherapy in patients with diffuse intrinsic pontine glioma, was comparable to the combination of aggressive radio-chemotherapy." Mr. Bach added, "Based on the results of this trial we intend to submit a Pediatric Investigation Plan (PIP) to the EMEA forthwith which, if approved by the Pediatric Committee (PDCO) would support a submission for marketing authorization."

Oncoscience reported that patients were able to stay at home or attend school while undergoing treatment with nimotuzumab. After 24 weeks PR and SD was reported in 76% of the children and the median survival of all patients was 9.6 months, with responders having a median survival of 11.4 months. After one year of treatment, 14 of the 41 patients (34%) were reported alive compared to a historical rate of 39.9% (+/- 4.3%) reported for
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4

Related biology technology :

1. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
2. Selection of Development Candidate Triggers $0.5 Million Milestone Payment to Ardea Biosciences, Inc.
3. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
4. ONCOSCIENCE AG, THE EUROPEAN PARTNER OF YM BIOSCIENCES, ANNOUNCES COMPLETION OF PATIENT ENROLLMENT IN PHASE III BRAIN CANCER TRIAL OF NIMOTUZUMAB
5. Pressure BioSciences, Inc. Reports Second Quarter 2007 Financial Results and Provides Business Update
6. YM BIOSCIENCES, EUROPEAN PARTNER, ONCOSCIENCE AG, ANNOUNCES INITIATION OF ADVANCED NIMOTUZUMAB TRIALS IN ADULT GLIOMA AND PANCREATIC CANCER
7. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2007
8. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
9. Pressure BioSciences, Inc. Issued First Patent in Canada
10. Neurocrine Biosciences to Present at the BioCentury: Newsmakers in the Biotech Industry Conference
11. YM BioSciences USA cleared by US FDA to initiate Phase II clinical trial of nimotuzumab in children with inoperable, recurrent brain cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... recipient,s immune system identifies the transplanted organ as foreign ... T cells, the immune cells that mediate rejection, must ... order to migrate to the transplanted organ. In this ... Fadi Lakkis and colleagues at the University of Pittsburgh ... cells is not required for migration. Instead, these cells ...
(Date:5/17/2013)... - Elsevier, a world-leading provider of scientific, technical and ... of a recent study in Reproductive BioMedicine ... that those with an abnormal chromosomal composition can be ... to blastocysts, thereby classifying the risk of genetic abnormality ... group has undertaken a retrospective study, using their predictive ...
(Date:5/17/2013)... TRIANGLE PARK, N.C., USA (PRWEB) May 17, 2013 ...     Green Globes Certified for sustainability , ... and insect pressures , Syngenta ... opening celebration today at the company’s RTP Innovation Center. ... Lab allows company researchers to simulate any agricultural climate ...
(Date:5/17/2013)... Calif. , May 17, 2013  Cellular ... has achieved 50% enrollment of the total projected ... evaluate the safety and preliminary efficacy of the ... therapy for Knee Osteoarthritis (KOA). To date the ... reported. The Phase I open label ...
Breaking Biology Technology:Breakthrough for IVF? 2Breakthrough for IVF? 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis 2
... China , May 25 /PRNewswire-Asia-FirstCall/ -- Biostar,Pharmaceuticals, Inc. ... a leading over-the-counter Hepatitis B medicine,Xin Aoxing Oleanolic Acid Capsule ("Xin ... that it has,commenced assembly of its production line for its proprietary ... , ...
... , NEW YORK , May 25 Pfizer Animal ... in aquaculture vaccines, R&D and healthcare diagnostic services.  The acquisition further expands ... cattle, swine, poultry and, now, fish. , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20100416/PFIZERLOGO ) , ...
... 25 Today Organic Miracle, Inc. CEO Jerry Bakke , ... have developed a natural, non-toxic solution to the Gulf oil spill contamination ... , , , ... 701 (Building a Better World Green) is a super concentrated, high efficiency, ...
Cached Biology Technology:Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 2Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 3Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line 4Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 2Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 3Pfizer Animal Health Expands Global Commitment to a Safe Food Supply with a New Focus on Healthy Fish 4Organic Miracle, Inc.'s Product, BBW G701, is a Natural, Non-Toxic Means of Stopping and Reversing the Catastrophic Contamination Caused by the Gulf Oil Spill 2
(Date:5/16/2013)... that are about 23 million years old give ... gobioid order, one of the most species-rich groups ... by paleontologist Professor Bettina Reichenbacher from the Division ... Earth and Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in ... of fish fossils which they assign to the ...
(Date:5/16/2013)... Abwe, a conservationist working in Cameroon and the manager ... just been awarded the prestigious Whitley award. The ... called "The Green Oscars" because it celebrates the extraordinary ... in developing countries. Abwe was selected for the ... preserve Cameroon,s Ebo Forest and its wildlife inhabitants., HRH ...
(Date:5/15/2013)... gout risk, new research reveals that vitamin C, also ... levels to a clinically significant degree in patients with ... with allopurinol, appears to have a weak effect on ... the results published in the American College of Rheumatology ... Gout is an inflammatory arthritis that causes excruciating pain ...
Breaking Biology News(10 mins):Paleontology: The eloquence of the otoliths 2Paleontology: The eloquence of the otoliths 3Cameroon researcher wins prestigious 'Green Oscar' 2Cameroon researcher wins prestigious 'Green Oscar' 3Vitamin C does not lower uric acid levels in gout patients 2
... Clinicians, researchers and allied health professionals with ... and management, are invited to convene in Singapore ... Meeting from December 10-13, 2010. The ... lectures by key international experts and thought leaders ...
... 2010) Rare but devastating, eye cancer can strike anyone ... leaves half of all patients partially blind. But a ... the University of Colorado School of Medicine, may change all ... the eye can block up to 55 percent of harmful ...
... broken by Michigan State University biochemists helps explain ... could lead to discoveries related to plant tolerance ... brings together two classic problems in plant biology," ... molecular biology. "One is that plants protect themselves ...
Cached Biology News:Clinical management of osteoporosis to be focus of Singapore meeting 2Researcher finds revolutionary way to treat eye cancer 2Researchers discover novel mechanism protecting plants against freezing 2